NUTRA PHARMA CORP Quarterly Return On Equity in % from Q1 2012 to Q3 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Nutra Pharma Corp quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2022.
  • Nutra Pharma Corp Return On Equity for the quarter ending September 30, 2022 was -41.3 %, a 170% decline year-over-year.
  • Nutra Pharma Corp annual Return On Equity for 2021 was 41.4 %, a 445% increase from 2020.
  • Nutra Pharma Corp annual Return On Equity for 2020 was 7.6 %, a 90.3% decline from 2019.
  • Nutra Pharma Corp annual Return On Equity for 2019 was 78.1 %, a 8.36% increase from 2018.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -41.3 -100 -170% Jul 1, 2022 Sep 30, 2022
Q2 2022 -115 -239 -192% Apr 1, 2022 Jun 30, 2022
Q1 2022 -104 -303 -152% Jan 1, 2022 Mar 31, 2022
Q4 2021 41.4 +33.8 +445% Oct 1, 2021 Dec 31, 2021
Q3 2021 58.9 +31.6 +116% Jul 1, 2021 Sep 30, 2021
Q2 2021 124 +85.1 +217% Apr 1, 2021 Jun 30, 2021
Q1 2021 199 +155 +351% Jan 1, 2021 Mar 31, 2021
Q4 2020 7.6 -70.5 -90.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 27.2 -17.7 -39.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 39.3 -18.2 -31.6% Apr 1, 2020 Jun 30, 2020
Q1 2020 44 -13.9 -24% Jan 1, 2020 Mar 31, 2020
Q4 2019 78.1 +6.02 +8.36% Oct 1, 2019 Dec 31, 2019
Q3 2019 44.9 -36.6 -44.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 57.4 -25.6 -30.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 57.9 -20.5 -26.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 72 -5.68 -7.31% Oct 1, 2018 Dec 31, 2018
Q3 2018 81.5 -1.55 -1.87% Jul 1, 2018 Sep 30, 2018
Q2 2018 83 +3 +3.75% Apr 1, 2018 Jun 30, 2018
Q1 2018 78.4 +3.96 +5.32% Jan 1, 2018 Mar 31, 2018
Q4 2017 77.7 -4.69 -5.69% Oct 1, 2017 Dec 31, 2017
Q3 2017 83.1 +40.2 +93.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 80 -39.9 -33.3% Apr 1, 2017 Jun 30, 2017
Q1 2017 74.4 -69.2 -48.2% Jan 1, 2017 Mar 31, 2017
Q4 2016 82.4 -47.7 -36.7% Oct 1, 2016 Dec 31, 2016
Q3 2016 42.9 -123 -74.1% Jul 1, 2016 Sep 30, 2016
Q2 2016 120 +37.5 +45.5% Apr 1, 2016 Jun 30, 2016
Q1 2016 144 +70.2 +95.7% Jan 1, 2016 Mar 31, 2016
Q4 2015 130 +63 +93.8% Oct 1, 2015 Dec 31, 2015
Q3 2015 166 +106 +178% Jul 1, 2015 Sep 30, 2015
Q2 2015 82.4 -32.1 -28% Apr 1, 2015 Jun 30, 2015
Q1 2015 73.4 -25.6 -25.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 67.1 -39.3 -36.9% Oct 1, 2014 Dec 31, 2014
Q3 2014 59.7 -88.7 -59.8% Jul 1, 2014 Sep 30, 2014
Q2 2014 114 +22.3 +24.2% Apr 1, 2014 Jun 30, 2014
Q1 2014 99 +20.6 +26.3% Jan 1, 2014 Mar 31, 2014
Q4 2013 106 +12.4 +13.2% Oct 1, 2013 Dec 31, 2013
Q3 2013 148 +45.9 +44.8% Jul 1, 2013 Sep 30, 2013
Q2 2013 92.2 -31.6 -25.5% Apr 1, 2013 Jun 30, 2013
Q1 2013 78.4 -75.5 -49.1% Jan 1, 2013 Mar 31, 2013
Q4 2012 94 Oct 1, 2012 Dec 31, 2012
Q3 2012 102 Jul 1, 2012 Sep 30, 2012
Q2 2012 124 Apr 1, 2012 Jun 30, 2012
Q1 2012 154 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.